AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

Quarterly Report Apr 30, 2025

8725_rns_2025-04-30_3ef482bb-dd3f-4e47-a389-612adf3bb997.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

CONVENIENCE TRANSLATION INTO ENGLISH OF FINANCIAL STATEMENTS AND NOTES FOR THE 31 MARCH 2025 TOGETHER WITH INDEPENDENT AUDITOR'S REPORT

(ORIGINALLY ISSUED IN TURKISH)

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ

CONTENTS PAGES
STATEMENT OF FINANCIAL POSITION 1-2
STATEMENT OF PROFIT OR LOSS 3
STATEMENT OF OTHER COMPREHENSIVE INCOME
4
STATEMENT OF CHANGES IN EQUITY
5
STATEMENT OF CASH FLOWS 6
NOTES TO THE FINANCIAL STATEMENTS
7-43

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ FINANCIAL STATEMENTS AS OF 31 MARCH 2025 AND 31 DECEMBER 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Unaudited Audited
Notes 31 March 2025 31 December 2024
Assets
Current assets
Cash and cash equivalences 4 475.773 725.684
Trade receivables 177.273 144.409
- Trade receivables from related parties 22 81.100 47.044
- Trade receivables from third parties 7 96.173 97.365
Other receivables 1.178 1.678
- Other receivables from third parties 8 1.178 1.678
Derivative Instruments 24.2 1.766 -
Inventories 9 958.052 868.875
Prepaid expenses 14 74.547 19.947
Current tax assets 14 123.332 133.949
Other current assets 88.203 78.159
- Other current assets from third parties 14 88.203 78.159
Total current assets 1.900.124 1.972.701
Non-current assets
Financial investments 5 1.409 1.436
Property, plant and equipment 10 870.675 869.379
Right of use assets 6 198.990 168.535
Intangible assets 11 89.641 97.636
Prepaid expenses 14 14.078 18.229
Total non-current assets 1.174.793 1.155.215
Total assets 3.074.917 3.127.916

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ FINANCIAL STATEMENTS AS OF 31 MARCH 2025 AND 31 DECEMBER 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Unaudited Audited
Notes 31 March 2025 31 December 2024
Liabilities
Current liabilities
Current borrowings 511.971 429.332
-Current borrowings from third parties 511.971 429.332
- Bank loans 6 - 429.332
- Issued debt instruments 6 511.971 -
Current portion of long-term borrowings 62.306 122.348
-Current portion of long-term borrowings from third parties 6 62.306 122.348
- Bank loans 53.422 30.785
- Lease liabilities 6.309 52.012
- Issued debt instruments 2.575 39.551
Trade payables 174.657 146.343
- Trade payables to related parties 22 20.477 7.912
- Trade payables to third parties 7 154.180 138.431
Employee benefit obligations 8 112.888 119.005
Other payables 3.973 4.214
- Other payables to third parties 8 3.973 4.214
Derivative instruments 24.2 - 617
Deferred income 14 156.384 67.197
Short term provision 32.383 20.929
- Provisions for employment benefits 13 27.122 15.147
- Other current provisions 12 5.261 5.782
Total current liabilities 1.054.562 909.985
Non-current liabilities
Non-current borrowings
582.302 557.342
- Non-current borrowings from third parties 6 582.302 557.342
- Bank loans 170.000 187.107
- Issued debt instruments 250.000 275.158
- Lease liabilities 162.302 95.077
Employee benefit obligations 8 2.269 2.548
Non-current provisions 34.860 36.762
- Non-current provision for employee benefits 13 34.860 36.762
Deferred tax liabilities 20 8.690 26.371
Total non-current liabilities 628.121 623.023
Equity
Paid-in share capital 15 259.875 259.875
Adjustment to share capital 15 375.318 375.318
Other comprehensive expense not to be
reclassified to profit or loss (19.853) (16.492)
- Revaluation and measurement gains / (losses) (19.853) (16.492)
Other comprehensive expense/(income) to be 15.137 13.723
reclassified to profit or loss
- Gains/(loss) on hedge 15.137 13.723
Restricted reserves appropriated from profits 15 328.633 331.661
Prior years' profits/(losses) 15 633.851 610.303
Net profit/(loss) for the period (200.727) 20.520
Total equity 1.392.234 1.594.908
Total liabilities and equity 3.074.917 3.127.916

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ PROFIT OR LOSS AS OF 1 JANUARY-31 MARCH 2025 AND 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Unaudited
1 January - 1 January -
Profit or loss Notes 31 March 2025 31 March 2024
Revenue 16 277.114 916.286
Cost of sales (-) 16 (170.368) (389.789)
Gross profit 106.746 526.497
General administrative expenses (-) (126.120) (112.223)
Marketing expenses (-) (153.832) (169.085)
Research and development expenses (-) (5.028) (4.200)
Other income from operating activities 17 2.904 14.198
Other expenses from operating activities (-) 17 (4.942) (60.861)
Operating profit / (loss) (180.272) 194.326
Income from investment activities 18 19 83
Expens from investment activities (-) 18 - (6.418)
Operating profit before finance income / (expense) (180.253) 187.991
Finance income 19 45.309 122.685
Finance expenses (-) 19 (133.979) (210.198)
Monetary gain / (loss) 25 51.110 60.941
Profit/(Loss) before tax from continuing operations (217.813) 161.419
Tax income from continuing operations 17.086 (40.615)
- Taxes on expense 20 - (50.286)
- Deferred tax income / (expense) 20 17.086 9.671
Net profit /(loss) for the year (200.727) 120.804
Profit /(loss) per share (1 TRL per share) 21 (0,7724) 5,1134

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ OTHER COMPREHENSIVE INCOME STATEMENTS FOR THE INTERIM PERIOD 1 JANUARY- 31 MARCH 2025 AND 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Unaudited
1 January - 1 January -
Notes 31 March 2025 31 March 2024
Net profit /(loss) for the year (200.727) 120.804
Other comprehensive income/expense
Other comprehensive expenses that will not be reclassified to profit or loss (3.361) 11.467
- Gains (Losses) on Remeasurements Defined Benefit Plans 13 (4.429) 15.288
Other comprehensive expenses that will not be reclassified to profit or loss, tax effect 1.068 (3.821)
- Deferred tax income / (expense) 1.068 (3.821)
Other comprehensive income / (expense) that will be reclassified to profit or loss 1.414 2.058
- Currency translation differences
- Other comprehensive income / (expense) on cash flow hedge
-Other Comprehensive income / (expense) on cash flow hedge 1.887 2.744
-Other comprehensive expenses that will be reclassified to profit or loss, tax effect (473) (686)
- Deferred tax income / (expense) (473) (686)
Other comprehensive income / (expense) (1.947) 13.525
Total comprehensive income (202.674) 134.329

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ STATEMENTS OF CHANGES IN EQUITY FOR THE PERIODS ENDED 1 JANUARY- 31 MARCH 2025 AND 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Other comprehensive
income (loss) that
Other comprehensive
will not be reclassified loss/(income) that will be
in profit or loss reclassified in profit or loss Accumulated profits
Inflation Defined benefit plans Currency
adjustment to revaluation and translation Gains/(loss) on Restricted Retained Net profit/(loss)
Share capital share capital measurement(losses)/gains differences hedge reserves earnings for the period Total equity
Balances as of 1 January 2024 23.625 611.570 (22.007) (6.258) 15.530 313.761 136.194 692.785 1.765.200
Transfers - - - - - - 692.785 (692.785) -
Liquidation effect - - - 6.258 - - - - 6.258
Total comprehensive income / (loss) - - 11.467 - 2.058 - - 120.804 134.329
Balances as of 31 March 2024 23.625 611.570 (10.540) - 17.588 313.761 828.979 120.804 1.905.787
Balances as of 1 January 2025 259.875 375.318 (16.492) - 13.723 331.661 610.303 20.520 1.594.908
Transfers - - - - - (3.028) 23.548 (20.520) -
Total comprehensive income / (loss) - - (3.361) - 1.414 - - (200.727) (202.674)
Balances as of 31 March 2025 259.875 375.318 (19.853) - 15.137 328.633 633.851 (200.727) 1.392.234

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ

CASH FLOW STATEMENTS FOR THE INTERIM 31 MARCH 2025 AND 31 MARCH 2024

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

Unaudited
1 January - 1 January -
Notes 31 March 2025 31 March 2024
Cash flow from operating activities (154.248) 163.538
Net profit /(loss) for the period (200.727) 120.804
Adjustments to reconcile net profit /(loss) for the period 113.232 198.230
Adjustments for depreciation and amortization expense 6,10,11 42.212 48.038
Adjustments for impairment loss/(reversal) 490 -
- Adjustments for impairment / (reversal) of receivables 7 490 -
Adjustments for provisions 13.622 22.789
- Adjustments for provisions / (reversal) for employee benefits 13 13.622 22.789
Adjustments for interest (income) / expense 121.549 149.789
- Adjustments for interest income 1 9 (10.923) (108.308)
- Adjustments for interest expense 1 9 132.472 210.126
- Rediscount on interest loss 1 6 - 54.589
- Rediscount on interest income 1 6 (6.618)
Adjustments for fair value (gain) / loss -
1.697
2.020
Adjustments for tax incomes 20 (17.086) 40.615
6.335
Adjustments for gain / (loss) on sale of tangible and intangible assets (19)
Monetary gain / (loss) (49.233) (71.356)
150.078
Changes in working capital (51.808)
Adjustments for decrease/(increase) in trade receivables (33.354) (151.579)
Adjustments for decrease/(increase) in other receivables 501 9.818
Adjustments for decrease/(increase) in inventory (89.177) 63.955
Decrease/(increase) in prepaid expenses (50.450) (100.781)
Adjustments for increase/(decrease) in trade payables 28.314 48.570
Adjustments for increase/(decrease) in employee benefit obligations (6.397) (42.297)
Adjustments for increase/(decrease) in other payables from operations (241) 7.366
Increase / (decrease) in deferred income (other than obligations 89.187 (72.755)
arising from customer contracts)
Adjustments for other increase/(decrease) in working capital 9.809 387.781
- Increase/(decrease) in other operating assets 28.021 387.820
- Increase/(decrease) in other operating liabilities (18.212) (39)
Cash flows from (used in) operating activities (139.303) 469.112
Payments related with provisions for employee benefits 13 (4.328) (2.386)
Income taxes (paid) return (10.617) (303.188)
Cash flow from investing activities (18.541) (19.142)
Cash inflows arising from sale of tangible and intangible assets 10 - (4.759)
Cash outflows arising from purchase of tangible and intangible assets 10 (18.541) (14.383)
Cash flow from financing activities (28.300) (243.919)
Proceeds from borrowings 6 500.000 113.977
Repayment of borrowings 6 (302.974) (267.588)
Repayment of lease liabilities (21.135) (19.467)
Interest paid 6 (211.397) (253.506)
Interest received 7.206 100.562
Other cash inflows (outflows) - 82.103
Monetary gain/(loss) impact on cash and cash equivalents (52.537) (162.865)
Net increase/(decrease) in cash and cash equivalents (253.626) (262.388)
Cash and cash equivalents at the beginning of the year 4 724.782 1.242.733
Cash and cash equivalents at the end of the year 4 471.156 980.345

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 1 - Company's organization and nature of operations

Adel Kalemcilik Ticaret ve Sanayi A.Ş. ("Company") operates in the production of pencils, colored pencils, toys, and other stationery products; the sale and export of finished goods manufactured at its facilities; and the import, trade, and distribution of raw materials, semi-finished, and finished products.

The company was established on 17 July 1967 and registered with the Istanbul Chamber of Industry (İSO) and the istanbul chamber of commerce (İTO) on the same date with the registration number 96078.

The registered address of the company's headquarters is as follows:

Fatih Sultan Mehmet Mahallesi Balkan Caddesi No:58 Buyaka E Blok 34771 Tepeüstü, Ümraniye/İstanbul.

The Company is registered to the Capital Markets Board ("CMB") and its shares have been traded on Borsa Istanbul ("BIST") since 1996. As of 31 March 2025, the Company has 27,71% of its shares registered in the BIST. The shareholders holding the majority of the Company's shares and their share ratios are as follows:

List of Shareholders

31 March 2025 31 December 2024
% TRL % TRL
AG Anadolu Grubu Holding A.Ş. 56,89 147.831 56,89 147.831
Faber-Castell Aktiengesellschaft 15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
259.875 259.875

The average number of employees of the Company as at 31 March 2025 is 339 (31 December 2024: 371).

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements

2.1 Basis of preparation and presentation of financial statements

2.1.1 Statement of compliance with TFRS

The accompanying financial statements are prepared in accordance with the requirements of Capital Markets Board ("CMB") Communiqué Serial II, No: 14.1 "Basis of Financial Reporting in Capital Markets", which was published in the Official Gazette No:28676 on June 13, 2013. The accompanying financial statements are prepared based on the Turkish Accounting Standards and interpretations ("TAS") issued by the Public Oversight Accounting and Auditing Standards Authority ("POA") under Article 5 of the Communiqué. It is also presented in accordance with the 2024 TFRS Taxonomy updated by POA on July 3, 2024.

The financial statements have been presented in accordance with the 2024 TFRS Taxonomy, which was developed based on the financial statement templates set out in the Financial Statement Samples and User Guide published by the Public Oversight, Accounting and Auditing Standards Authority (POA) in the Official Gazette dated June 7, 2019, issue No. 30794, and updated by POA on July 3, 2024.

The Company's companies operating in Türkiye maintain their books of account and prepare their statutory financial statements in Turkish Lira in accordance with the principles and requirements issued by the Capital Markets Board ("CMB"), the Turkish Commercial Code ("TCC") and Tax Legislation and the Uniform Chart of Accounts issued by the Ministry of Finance. Subsidiaries and joint ventures operating abroad maintain their books of account and prepare their statutory financial statements in accordance with the laws and regulations of the countries in which they operate.

The Company's financial statements as of 31 March 2025 were approved by the Company's Board of Directors on 16 April 2025. The Board is authorized to amend the financial statements.

2.1.2 Adjustment of financial statements in hyperinflationary periods

The Company prepared its financial statements as at and for the period ended June 30, 2024 by applying TAS 29 "Financial Reporting in Hyperinflationary Economies" in accordance with the announcement made by POA on 23 November 2023 and the "Implementation Guide on Financial Reporting in High Inflation Economies". The standard requires that financial statements prepared in the currency of a hyperinflationary economy be expressed in terms of the purchasing power of that currency at the balance sheet date and that comparative figures for prior period financial statements be expressed in terms of the measuring unit current at the end of the reporting period. Accordingly, the Company has also presented its financial statements as of 31 December 2024 in terms of the purchasing power of that currency as of 31 March 2025.

In accordance with the CMB's decision dated 28 December 2023 and numbered 81/1820, it has been decided that issuers and capital market institutions subject to financial reporting regulations applying Turkish Accounting/Financial Reporting Standards will apply inflation accounting in accordance with TAS 29 standards, starting from their annual financial reports for the accounting periods ending as of 31 December 2023.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

The restatements in accordance with TAS 29 have been made using the adjustment factor derived from the Consumer Price Index ("CPI") in Türkiye published by the Turkish Statistical Institute ("TSI"). As of March 31, 2025, the indexes and adjustment factors used in the restatement of the financial statements are as follows:

Date Index Adjustment
Coefficient
Three-Year Compound
Inflation Rate
31 March 2025 2.954,69 1,00000 %250
31 December 2024 2.684,55 1,10063 %291
31 March 2024 2.139,47 1,38104 %309

The main elements of the Company's adjustment for financial reporting purposes in high-inflation economies are as follows:

  • The current period financial statements prepared in TRL are expressed with the purchasing power at the balance sheet date, and the amounts from previous reporting periods are also expressed by adjusting according to the purchasing power at the end of the reporting period.
  • Monetary assets and liabilities are not adjusted as they are currently expressed with current purchasing power at the balance sheet date. In cases where the inflation-adjusted values of nonmonetary items exceed the recoverable amount or net realizable value, the provisions of TAS 36 and TAS 2 were applied, respectively.
  • Non-monetary assets and liabilities and equity items that are not expressed in current purchasing power at the balance sheet date have been corrected using the relevant correction coefficients.
  • All items included in the comprehensive income statement, except those that affect the statement of comprehensive income of non-monetary items in the balance sheet, are indexed with coefficients calculated over the periods when the income and expense accounts are first reflected in the financial statements.
  • The effect of inflation on the Company's net monetary asset position in the current period is recorded in the net monetary gain / loss account in the income statement.

2.1.3 Functional and reporting currency

The Company is based on the Turkish Commercial Code ("TCC"), tax legislation and the Uniform Chart of Accounts issued by the Ministry of Finance of the Republic of Türkiye in keeping its accounting records and preparing its statutory financial statements. Investments valued by the equity method in foreign countries, have prepared their statutory financial statements in accordance with the laws and regulations applicable in the countries in which they operate. Financial statements of company have been prepared in Turkish lira based on historical cost, excluding financial assets and liabilities that are expressed at their fair values. The financial statements have been prepared by reflecting the necessary adjustments and classifications to make the correct presentation in accordance with TMS/TFRS to the legal records prepared on the historical cost basis.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

2.1.4 Shares in affiliates and joint ventures

A partnership is a joint venture in which entities with joint control in an arrangement have rights to the equity in the joint arrangement. Joint control is based on the control contract on an economic activity.

This control is deemed to exist when the decisions of the relevant activities require the parties sharing the control to agree with the unanimity of votes.

The results and assets and liabilities of associates or joint ventures are incorporated in these financial statements using the equity accounting method, except when the investment, or a portion thereof, is classified as held for sales, in which case it is accounted for in accordance with TFRS 5. Under the equity method, an investment in associate or a joint venture is initially recognized in the financial statement of financial position at cost and adjusted thereafter to recognize the Company's share of the profit or loss and other comprehensive income of the associate or a joint venture.

When the Company's whare of losses of an associate or a joint venture exceeds the Company's interest in that associate or a joint venture (which includes any long term interests that, in substance, form part of the Company's net investment in the associate or a joint venture), the company discontinues recognizing its share of further losses. Additional losses are recognized only to the extent that the Company has incurred legal or constructive obligations or made payments on behalf of the associate or a joint venture.

2.1.5 Comparative information and restatement of prior period financial statements

Comparative figures are reclassified, where necessary, to conform to changes in presentation in the current period financial statements and significant changes are explained. The financial statements of the Company include comparative financial information to enable the determination of the trends in the financial position and performance. The Company has prepared its financial position statement as of 31 March 2025 with the financial position statement prepared as of 31 December 2024; The profit or loss statement for the period 1 January- 31 March 2025, the profit or loss statement for the 1 January- 31 March 2024 accounting period, and the other comprehensive income statement for the 1 January- 31 Match 2025 accounting period, the 1 January- 31 March 2024 accounting period, other comprehensive income statement, cash flow statement for the accounting period 1 January- 31 March 2025 and statements of changes in shareholders' equity are prepared comparatively with the related financial statements for the accounting period 1 January - 31 March 2024.

2.2 New and Revised Turkish Financial Reporting Standards

a) Standards, amendments, and interpretations applicable as of 31 March 2025:

Amendments to IAS 21 - Lack of Exchangeability; effective from annual periods beginning on or after 1 January 2025. An entity is impacted by the amendments when it has a transaction or an operation in a foreign currency that is not exchangeable into another currency at a measurement date for a specified purpose. A currency is exchangeable when there is an ability to obtain the other currency (with a normal administrative delay), and the transaction would take place through a market or exchange mechanism that creates enforceable rights and obligations.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.2 New and Revised Turkish Financial Reporting Standards (Continued)

  • b) Standards, amendments, and interpretations that are issued but not effective as of 31 Mart 2025:
  • Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments; effective from annual reporting periods beginning on or after 1 January 2026 (early adoption is available). These amendments:
    • clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system;
    • clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion;
    • add new disclosures for certain instruments with contractual terms that can change cash flows (such as some instruments with features linked to the achievement of environment, social and governance (ESG) targets); and
    • make updates to the disclosures for equity instruments designated at Fair Value through Other Comprehensive Income (FVOCI).
    • Annual improvements to IFRS – Volume 11; effective from annual periods beginning on or after 1 January 2026 (earlier application permitted). Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the Accounting Standards. The 2024 amendments are to the following standards:
      • IFRS 1 First-time Adoption of International Financial Reporting Standards;
      • IFRS 7 Financial Instruments: Disclosures and its accompanying Guidance on implementing IFRS 7;
      • IFRS 9 Financial Instruments;
      • IFRS 10 Consolidated Financial Statements; and
      • IAS 7 Statement of Cash Flows.
    • Amendment to IFRS 9 and IFRS 7 - Contracts Referencing Nature-dependent Electricity; effective from annual periods beginning on or after 1 January 2026 but can be early adopted subject to local endorsement where required. These amendments change the 'own use' and hedge accounting requirements of IFRS 9 and include targeted disclosure requirements to IFRS 7. These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because the source of its generation depends on uncontrollable natural conditions (such as the weather). These are described as 'contracts referencing nature-dependent electricity'.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.2 New and Revised Turkish Financial Reporting Standards (Continued)

  • b) Standards, amendments, and interpretations that are issued but not effective as of 31 Mart 2025(Continued)
  • IFRS 18 Presentation and Disclosure in Financial Statements; effective from annual periods beginning on or after 1 January 2027. This is the new standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in IFRS 18 relate to:
    • the structure of the statement of profit or loss;
    • required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity's financial statements (that is, managementdefined performance measures); and
    • enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general.
  • IFRS 19 Subsidiaries without Public Accountability: Disclosures; effective from annual periods beginning on or after 1 January 2027. This new standard works alongside other IFRS Accounting Standards. An eligible subsidiary applies the requirements in other IFRS Accounting Standards except for the disclosure requirements and instead applies the reduced disclosure requirements in IFRS 19. IFRS 19's reduced disclosure requirements balance the information needs of the users of eligible subsidiaries' financial statements with cost savings for preparers. IFRS 19 is a voluntary standard for eligible subsidiaries. A subsidiary is eligible if:
    • it does not have public accountability; and
    • it has an ultimate or intermediate parent that produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

2.3. Changes and errors in accounting estimates

Changes in accounting policies or accounting errors are applied retrospectively and the financial statements of the comparative period are restated. If estimated changes in accounting policies are for only one period, changes are applied on the current year but if the estimated changes are for the following periods, changes are applied both on the current and following years prospectively. Except for the subject mentioned in "Comparative Information and Restatement of Prior Period Financial Statements", the Company has not identified any significant accounting error or estimated changes in accounting policies in the current year.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.3. Changes and errors in accounting estimates (Continued)

The nature and amount of a change in the accounting estimate that has an effect on the current period's operating result or is expected to have an effect on the following periods is disclosed in the footnotes of the financial statements, unless it is not possible to estimate the effect on future periods. There has been no change or error in the accounting estimates of the financial statements for the 31 March 2025 accounting period.

2.4. Financial statements of a joint venture operating in a foreign country

The financial statements of the joint venture operating in a foreign country have been prepared in accordance with the legislation in force in the country in which it operates and have been prepared by reflecting the necessary corrections and classifications in order to comply with the "Communiqué on the Principles of Financial Reporting in the Capital Markets".

The assets and liabilities of subsidiaries and joint ventures operating in foreign countries are translated at the rate of exchange ruling at the balance sheet date and the income statements of foreign subsidiaries and joint ventures are translated at average exchange rates. Differences that occur by the usage of closing and average exchange rates are followed under currency translation differences classified under equity.

2.5. Seasonality of activities

At the beginning of the year, the Company launches a sales campaign for specific products, followed by "dealer fairs" held in the first quarter to promote the sales of its manufactured and imported brands. During these campaigns and dealer fairs, customer orders are secured through checks, Direct Debit System (DDS), or credit cards. A significant portion of the orders received is shipped within the first half of the year.

2.6. Significant accounting judgments, estimates and assumptions

Fair values of derivatives and other financial instruments

Derivatives are recognized initially at fair value at the date a derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. The resulting gain or loss is recognized in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

Expected credit losses

Provision for doubtful receivables is recognized using expected credit losses as defined in TFRS 9. The allowance for doubtful receivables is calculated using expected credit losses and excluding dealers subject to the Direct Debit System, taking into account the Company's estimates for the future in addition to past experience.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 2 - Basis of presentation of financial statements (Continued)

2.7. Incentives Provided by the State

Government incentives are not recognized unless there is a reasonable reason to believe that the Company fulfills the requirements of these incentives and that this incentive will be received. These incentives are recognized in revenues in the period to match the costs they are expected to cover. Income from government incentives is recognized as a deduction from an appropriate expense item.

NOTE 3 - Segment reporting

Fields of activity of the Company established in Türkiye are the production of pencils, colored pencils, toys, and other stationery equipment; the sale and export of finished products in the facilities; and the import of all kinds of raw materials, semi-finished products, and finished products for purchase and sale.

The Company's field of activity, the nature and economic characteristics of the products, the production processes, the classification according to the risks of the customers and the methods used in the distribution of the products are similar. In addition, the organizational structure of the Company has been established in such a way that a single activity is managed instead of the Company being managed in separate divisions containing different activities. For these reasons, the Company's operations are considered as a single operating segment, and the Company's operating results, the determination of the resources to be allocated to these activities, and the examination of the performances of these activities are evaluated within this framework.

NOTE 4 - Cash and cash equivalents

31 March 2025 31 December 2024
Demand deposit 460.716 38.768
Time deposit 4.063 179
Other cash equivalents 6.377 685.835
Cash and cash equivalents in the statement of cash flows 471.156 724.782
Interest income accruals 4.617 902
Total 475.773 725.684

The Company has no blocked deposits as of 31 March 2025 (31 December 2024: None).

As of 31 March 2025, the Company has allocated USD 309.137 equivalent of TRL 11.675 from its bank deposits for the payments related to raw material and trade goods purchases to be made in the future periods in order to hedge against fluctuations in foreign exchange rates and the related amount has been subject to hedge accounting. (31 December 2024: USD 1.000.000 equivalent of TRL 48.644)

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 5 - Financial investments

31 March 2025 31 December 2024
% TRL % TRL
Ülkü Kırtasiye Ticaret ve Sanayi A.Ş. 7,67 9 9 7,67 9 9
Other long-term investments (*) 1.310 1.337
1.409 1.436

(*) It is the amount of venture capital investment fund received by the Company on a long-term basis, equivalent to 2% of the corporate tax incentive utilized, as a result of its status as an R&D center.

NOTE 6 - Borrowings and right of use assets

31 March 2025 Interest rate % Balance
Short term borrowings
Debt instruments issued (*) TLref + %1 511.971
511.971

The Company has issued debt instruments amounting to TRL 500.000 offered exclusively to qualified investors without a public offering in the domestic market. These instruments have a maturity of 364 days, bear a variable interest rate of BIST TRLREF + 100 bps, feature two coupon payments, and are set to mature on March 13, 2026.

As of 31 March 2025, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans, and the interest accrual calculated for the issued debt instruments is classified within the issued debt instruments.

31 March 2025 Interest rate % Balance
Short-term portions of long-term borrowings
Short-term portions of long-term finance leases 14,00 - 45,00 6.309
Short-term portions of long-term loans TLref + %1 53.422
Short-term portions of long-term issued debt instruments (*) TLref + %1 2.575
62.306

As of 31 March 2025, the interest accrual calculated for the short-term parts of the Company's longterm borrowings is classified within the short-term parts of the relevant long-term borrowings.

31 March 2025 Interest rate % Balance
Long term borrowings
TRL loans TLref + %1 170.000
Debt instruments issued (*) TLref + %1 250.000
Long-term lease payables 34,00 - 45,00 162.302
582.302

(*) The Company has issued debt instruments amounting to TRL 250.000, offered exclusively to qualified investors without a public offering in the domestic market. These instruments have a maturity of 730 days, bear a variable interest rate of BIST TRLREF + 100 bps, feature four coupon payments, and are set to mature on September 24, 2026.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 6 - Borrowings and right of use assets (Continued)

The details of the Company's short and long-term borrowings as of 31 December 2024 are as follows;

31 December 2024 Interest rate % Balance
Short term borrowings
TRL loans 48,00 - 54,00 429.332
429.332

As of 31 December 2024, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans.

31 December 2024 Interest rate % Balance
Short-term portions of long-term borrowings
Short-term portions of long-term finance leases 8,45 52.012
Short-term portions of long-term loans TLref + %1 30.785
Short-term portions of long-term issued debt instruments TLref + %1 39.551
122.348

As of 31 December 2024, the interest accrual calculated for the short-term parts of the Company's longterm borrowings is classified within the short-term parts of the relevant long-term borrowings.

31 December 2024 Interest rate % Balance
Long term borrowings
TRL loans TLref + %1 187.107
Debt instruments issued (*) TLref + %1 275.158
Long-term lease payables 14,89 - 21,10 95.077
557.342

As of 31 March 2025 and 31 December 2024, the maturity details of the Company's long-term loans and financial lease borrowings are given below:

Total
liabilities
582.302
582.302
Total
liabilities
557.342
557.342

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 6 - Borrowings and right of use assets (Continued)

The movement of bank loans is as follows:

2025 2024
1 January 961.932 1.592.661
Cash inflows from borrowing 500.000 113.977
Cash outflows related to debt payments (302.974) (267.588)
Interest expense 120.381 203.022
Interest paid (211.397) (253.506)
Monetary (gain) / loss (79.974) (203.680)
31 March 987.968 1.184.886

The movement table of lease liabilities is as follows:

2025 2024
1 January 147.089 175.505
Cash outflows related to lease payments for the period (21.135) (19.467)
Interest expense 12.091 7.104
Contract amendment 47.410 -
Monetary (gain) / loss (16.844) (22.478)
31 March 168.611 140.664

The movement table of the right-of-use assets of the Company as of 31 March 2025 and 31 December 2024 is given below:

Right of use assets Vehicles Buildings Total
As of 1 January 2025 35.422 133.113 168.535
Changes in contracts - 47.410 47.410
Current depreciation expense (*) (7.047) (9.908) (16.955)
As of 31 March 2025 28.375 170.615 198.990

(*) TRL 118 of depreciation expenses are included in the cost of goods sold, TRL 3.257 in general administrative expenses, and TRL 13.580 in marketing, sales and distribution expenses.

Right of use assets Vehicles
Buildings
Total
As of 1 January 2024 44.457 169.720 214.177
Disposal (2.928) - (2.928)
Current depreciation expense (*) (6.567) (13.417) (19.984)
As of 31 March 2024 34.962 156.303 191.265

(*) TRL 113 of depreciation expenses are included in the cost of goods sold, TRL 2.077 in general administrative expenses, and TRL 17.794 in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 7 - Trade receivables and payables

Trade receivables from related parties (Note 22)
81.100
47.044
Trade receivables from third parties
96.173
97.365
177.273
144.409
Trade receivables from third parties
31 March 2025
31 December 2024
Cheques and notes receivables
201
1.732
Trade receivables
103.879
103.845
Provisions for doubtful trade receivables (-)
(7.907)
(8.212)
96.173
97.365
2025
and 2024,
the movement table for doubtful trade receivables is as follows:
2025
2024
1 January
8.212
10.136
Provision provided during the period
495
-
Reversal of provision
(5)
-
Monetary (gain) / loss
(795)
(1.327)
31 March
7.907
8.809
31 March 2025
31 December 2024
Trade payables
Trade payables to related parties (Note 22)
20.477
7.912
Trade payables to third parties
154.180
138.431
174.657
146.343
Trade payables to third parties
31 March 2025
31 December 2024
Suppliers
154.093
131.663
Other trade payables
8 7
6.768
154.180
138.431
-
Other receivables
and payables
Other receivables
31 March 2025 31 December 2024
Other receivables from third parties
1.178
1.678
1.178
1.678
Trade Receivables 31 March 2025 31 December 2024
As of 31 March
NOTE 8
Other receivables from third parties 31 March 2025 31 December 2024
Receivables from employees 702 1.095
Deposits and guarantees given 348 386
Other miscellaneous receivables 128 197
1.178 1.678

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 8 - Other receivables and payables (Continued)

Other payables 31 March 2025 31 December 2024
Other payables to third parties 3.973 4.214
3.973 4.214
Other payables to third parties 31 March 2025 31 December 2024
Taxes, fees and deductions payable 3.079 3.469
Other 894 745
3.973 4.214
Employee benefit obligations 31 March 2025 31 December 2024
Payables to employees 79.312 68.838
Social security premiums payable 23.897 10.288
Taxes, fees and deductions payable 9.679 39.879
112.888 119.005
Long-term employee benefit obligations 31 March 2025 31 December 2024
Payables to employees 2.269 2.548
2.269 2.548

NOTE 9 – Inventories

31 March 2025 31 December 2024
Raw materials 276.012 231.514
Semi-finished goods 113.260 112.121
Finished goods 370.767 293.706
Trade goods 212.876 246.598
Other inventories 12.826 12.625
Provision for impairment of inventories (-) (*) (27.689) (27.689)
958.052 868.875

(*) As of 31 March 2025 and 2024, the movement table regarding the stock impairment provision allocated as a result of the evaluation regarding the recoverability of stocks is as follows:

2025 2024
1 January 27.689 25.992
Provisions no longer required (-) - -
31 March 27.689 25.992

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 10 - Property, plant and equipment

Lands Land
improvements
and buildings
Buildings Machinery and
equipment
Vehicles Furniture and
fixtures
Construction in
progress
Special Cost Total
As
of
1
January
2025,
Cost 47.709 22.602 745.473 1.040.786 16.677 283.299 28.956 5.029 2.190.531
Accumulated
depreciation
- (20.767) (153.683) (873.937) (16.649) (252.291) - (3.825) (1.321.152)
Net
book
value
47.709 1.835 591.790 166.849 2
8
31.008 28.956 1.204 869.379
Opening
balance
47.709 1.835 591.790 166.849 2
8
31.008 28.956 1.204 869.379
Additions - - - 569 - 3.463 14.526 - 18.558
Depreciation
(*)
- (75) (3.760) (10.538) (5) (2.782) - (102) (17.262)
Closing
balance
47.709 1.760 588.030 156.880 2
3
31.689 43.482 1.102 870.675
As
of
31
2025,
March
Cost 47.709 22.602 745.473 1.041.355 16.677 286.762 43.482 5.029 2.209.089
Accumulated
depreciation
- (20.842) (157.443) (884.475) (16.654) (255.073) - (3.927) (1.338.414)
Net
book
value
47.709 1.760 588.030 156.880 2
3
31.689 43.482 1.102 870.675

(*) TRL 13.481 of depreciation expenses are included in the cost of goods sold, TRL 612 in general administrative expenses, TRL 637 in research and development expenses and TRL 2.532 in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 10 - Property, plant and equipment (Continued)

Lands Land
improvements
and buildings
Buildings Machinery and
equipment
Vehicles Furniture and
fixtures
Construction in
progress
Special Cost Total
As
of
1
2024,
January
Cost
47.709
22.602 743.246 1.028.012 16.677 278.372 - 5.752 2.142.370
Accumulated
depreciation
(20.456)
-
(135.751) (835.265) (16.637) (246.482) - (2.354) (1.256.945)
47.709
Net
book
value
2.146 607.495 192.747 4
0
31.890 - 3.398 885.425
Opening
47.709
balance
2.146 607.495 192.747 4
0
31.890 - 3.398 885.425
Additions -
-
- 3.172 - 3.157 8.053 - 14.382
Disposal
cost
-
-
- - - (3.341) - - (3.341)
Disposal
depreciation
-
-
- - - 1.799 - - 1.799
Depreciation
(*)
(75)
-
(3.987) (10.375) (14) (3.322) - (97) (17.870)
Closing
balance
47.709
2.071 603.508 185.544 2
6
30.183 8.053 3.301 880.395
As
of
31
March
2024,
Cost
47.709
22.602 743.246 1.031.184 16.677 278.188 8.053 5.752 2.153.411
Accumulated
depreciation
(20.531)
-
(139.738) (845.640) (16.651) (248.005) - (2.451) (1.273.016)
Net
book
value
47.709
2.071 603.508 185.544 2
6
30.183 8.053 3.301 880.395

(*) TRL 13.922 of depreciation expenses is included in the cost of goods sold, 401 TRL is included in general administrative expenses, 367 TRL is included in research and development expenses, and 3.180 TRL is included in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 11 - Intangible assets

Intangible assets include computer software, rights and development costs.

License Other intangible Total
Rights Developments agreements assets
As of 1 January 2025,
Cost 3.532 96.639 262.675 22.370 385.216
Accumulated amortizations (3.296) (34.017) (227.775) (22.492) (287.580)
Net book value 236 62.622 34.900 (122) 97.636
Opening balance 236 62.622 34.900 (122) 97.636
Additions - - - - -
Depreciation (*) (27) (4.554) (2.794) (620) (7.995)
End of the period 209 58.068 32.106 (742) 89.641
As of 31 March 2025, -
Cost 3.532 96.639 262.675 22.370 385.216
Accumulated amortizations (3.323)
-
(38.571)
-
(230.569)
-
(23.112)
-
(295.575)
-
Net book value 209 58.068 32.106 (742) 89.641

(*) For the current period, amortization shares include TRL 4.584 in the cost of goods sold, TRL 666 in general administrative expenses, TRL 1.477 in research and development expenses and TRL 1.268 in marketing, sales and distribution expenses, has been made.

Rights Developments License
agreements
Other intangible
assets
Total
As of 1 January 2024,
Cost 3.532 94.837 252.126 20.832 371.327
Accumulated amortizations (3.106) (15.019) (210.574) (17.096) (245.795)
Net book value 426 79.818 41.552 3.736 125.532
Opening balance 426 79.818 41.552 3.736 125.532
Additions - - - - -
Depreciation (*) (47) (4.575) (5.561) - (10.183)
End of the period 379 75.243 35.991 3.736 115.349
As of 31 March 2024,
Cost 3.532 94.837 252.126 20.832 371.327
Accumulated amortizations (3.153) (19.594) (216.135) (17.096) (255.978)
Net book value 379 75.243 35.991 3.736 115.349

(*) For the current period, amortization shares include TRL 3.139 in the cost of goods sold, TRL 519 in general administrative expenses, TRL 1.483 in research and development expenses, and TRL 5.043 in marketing, sales and distribution expenses, has been made.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 12 - Provisions, contingent assets and liabilities

31 March 2025 31 December 2024
Provisions for lawsuits 5.261 5.782
5.261 5.782

15 employees of the Company have filed 15 lawsuits against the Company for the cancellation of their employment contracts, reinstatement and other compensation claims and a provision for lawsuits amounting to TRL 5.261 has been set aside as a result of the evaluations of the lawyers in relation to the related lawsuits.

As of 31 March, 5.261 258
Monetary (gain) / loss (521) (39)
As of 1 January, 5.782 297
2025 2024

Contingent liabilities and contingent assets

The Company's was unable to collect its receivable of TRL 60 arising from its current account relationship with its customer. As a result, enforcement proceedings were initiated under Istanbul 18th Enforcement Directorate file numbers 2012/20785E and 2012/18797E, as well as Kartal 1st Enforcement Directorate file number 2012/6142E. The sale of the seized real estate was requested on October 7, 2013. The valuation report has been notified, and the real estate sales process is ongoing.

2014/14137E, 2014/15246E, 2014/16896E, filed under Izmir 2, 8, 10 and 14th Enforcement Directorate, as a result The Company's inability to collect its receivable of TRL 594 arising from its current account relationship with its customer and 2015/574E, enforcement proceedings were initiated against the debtor company, and a payment order notification was issued against the debtor company, by proceeding with the main proceeding through a lien specific to bills of exchange. Investigations continue for the purpose of collecting the receivable.

There are commercial lawsuits filed against The Company's by the employees of the two subcontractors, whose contracts the Company's terminated as of 31 August 2013, due to their failure to fulfill their legal obligations towards their employees, within the framework of the principles of joint and several liability. Provision has been made as of 31 March 2025. The company has objected to the enforcement proceedings in question and the proceedings are continuing.

Following the failure of The Company's to collect its receivables arising from its current account relationship with its customer, a lawsuit was filed with the file number 2016/12354 E (New Basis: 2021/14645 E.) filed within the Istanbul Anatolian 17th Enforcement Directorate. Provision has been made for the amount. Main proceedings have been initiated and the assets recorded on the debtor have been inquired about. There are no assets registered in the name of the debtor, investigations are continuing to collect the receivable.

Following the inability of The Company's to collect due to its current account relationship with its customer, a receivable was recorded in the bankruptcy estate with the file number 2017/32 at Istanbul Anadolu 3rd Bankruptcy Directorate. A provision has been made for the said amount. The aforementioned lawsuits do not have a material impact on the Company's financial position, operating results, or liquidity.

The Company's has initiated follow-up with the file number 2024/25778 E within the Gebze Enforcement Office, since the 495 TRL advance payment with its supplier could not be collected, and the corresponding amount was obtained. The main follow-up has been initiated and the assets registered under the debtor have been inquired. There are no assets registered under the debtor's name, and the investigation is ongoing for the purpose of collecting the money.

The lawsuits in question are not of a nature that could significantly affect the Company's operating results, financial position or liquidity.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 12 - Provisions, contingent assets and liabilities (Continued)

Deposits and guarantees given 31 March 2025 31 December 2024
Letters of guarantee 12.706 17.796
Letter of credit commitments 41.389 42.486

As of 31 March 2025 and 31 December 2024, the tables regarding the Company's collateral/pledge/mortgage ("CPM") position are as follows:

31 March 2025

Letter of guarantees, pledge and mortgages provided by the Company TRL equivalents EUR TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 12.706 2 12.610
B. Total amount of GPMs given in favor of subsidiaries included in full
consolidation
- - -
Total amount of GPMs given by the Company for the liabilities of 3rd parties
C. in - - -
order to run ordinary course of business
D. Total amount of other GPM's - - -
i. Total amount of GPMs given in favor of the parent Company - - -
ii. Total amount of GPMs given in favor of other group companies not in the
scope - - -
of B and C above
iii. Total amount of GPMs given in favor of third party companies not in the
scope of C above - - -
12.706 2 12.610

31 December 2024

Letter of guarantees, pledge and mortgages provided by the Company TRL equivalents EUR TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 17.796 - 17.796
B. Total amount of GPMs given in favor of subsidiaries included in full
consolidation
- - -
in C. Total amount of GPMs given by the Company for the liabilities of 3rd parties - - -
order to run ordinary course of business
D. Total amount of other GPM's
- - -
i. Total amount of GPMs given in favor of the parent Company - - -
ii. Total amount of GPMs given in favor of other group companies not in the
scope
of B and C above
- - -
iii. Total amount of GPMs given in favor of third party companies not in the
scope of C above
- - -
17.796 - 17.796

The ratio of other CPMs given by the Company to the Company's equity capital is 0% as of 31 March 2025 (31 December 2024: 0%).

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 13 - Employee benefits

Short term employee benefits 31 March 2025 31 December 2024
Premium accruals 18.458 12.539
Provisions for unused vacations 8.664 2.608
27.122 15.147
Long term employee benefits 31 March 2025 31 December 2024
Provisons for employment termination benefits 34.860 36.762
34.860 36.762

The movement table of unused vacation accruals as of 31 March 2025 and 2024 is as follows:

2025 2024
As of 1 January, 2.608 4.093
Addition 8.464 6.244
Provision for vacation used (2.020) (1.440)
Monetary (gain) / loss (388) (536)
As of 31 March 8.664 8.361

Provisions for employee termination benefits

In accordance with the provisions of the Labor Law in force, there is an obligation to pay the legal severance pay to employees whose employment contract has ended so that they are entitled to severance pay. In addition, in accordance with the legislation currently in force, there is an obligation to pay the legal severance pay to those who have the right to leave the job by receiving severance pay. As of 1 January 2025, the severance pay to be paid is subject to a monthly ceiling of full TRL 46.655,43 (1 January 2024: full TRL 35.058,58). Severance pay liability is not legally subject to any funding. Severance pay liability is calculated based on the estimation of the present value of the company's possible future liability arising from the retirement of employees. TAS 19 ("Employee Benefits") requires the company to develop its liabilities within the scope of defined monthly plans using actuarial valuation methods. Accordingly, the actuarial assumptions used in calculating total liabilities are stated below:

Severance pay liability is not legally subject to any funding. The severance pay provision is calculated by estimating the present value of the future probable obligation of the company arising from the retirement of its employees. TAS 19 ("Employee Benefits") requires the company's liabilities to be developed using actuarial valuation methods within the scope of defined benefit plans. Accordingly, the actuarial assumptions used in the calculation of total liabilities are as follows:

The main assumption is that the maximum liability for each year of service increases in line with inflation. Therefore, the discount rate applied represents the expected real rate after adjusting for the effects of future inflation. As of 31 March 2025 and 31 December 2024, provisions in the attached financial statements are calculated by estimating the present value of the possible future liability arising from the retirement of employees.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 13 - Employee benefits (Continued)

2025 2024
As of 1 January 36.762 45.908
Service cost (761) 8.901
Severance pay paid (2.308) (946)
Actuarial (gain) / loss 4.429 (15.288)
Monetary (gain) / loss (3.262) (6.197)
31 March 34.860 32.378
31 March 2025 31 December 2024
Discount rate (%) 2,58 2,58
Turnover rate used in retirement probability calculation (%) 92,64 92,82
NOTE
14
-
Other assets and liabilities
Short-term prepaid expenses 31 March 2025 31 December 2024
Advances given 55.682 14.960
Prepaid expenses for the coming months 18.865 4.987
74.547 19.947
Current tax assets 31 March 2025 31 December 2024
Prepaid taxes and funds 123.332 133.949
123.332 133.949
Other current assets 31 March 2025 31 December 2024
Deffered VAT 88.036 78.088
Other miscellaneous current assets 167 7 1
88.203 78.159
Long-term prepaid expenses 31 March 2025 31 December 2024
Prepaid expense for the following years 14.078 18.229
14.078 18.229
Deffered income 31 March 2025 31 December 2024
Advances received 156.384 67.197
156.384 67.197

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 15 - Capital, reserves and other equity items

Capital

The shareholders of the Company and their shares in the capital are given below.

31 March 2025 31 December 2024
% Share Balance % Share Balance
AG Anadolu Grubu Holding A.Ş. 56,89 147.831 56,89 147.831
Faber - Castell Aktiengesellschaft 15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
Paid in capital 100,00 259.875 100,00 259.875
Inflation adjustment to share capital 375.318 375.318
Total capital 635.193 635.193

Capital adjustment differences express the effect of realigning cash additions to paid-in capital with year-end purchasing power.

Number of shares, share groups and privileges:

The Company has 40.017.351 registered shares amounting to TRL 40.017 and 219.857.649 registered shares amounting to TRL 219.858 in accordance with the Foreign Capital Legislation. There are no privileges granted to shareholders in the election of the board of directors.

Restricted reserves allocated from profit

According to the Turkish Commercial Code, legal reserves are divided into two: first and second legal reserves. According to the Turkish Commercial Code, the first legal reserves are allocated as 5% of the legal net profit until 20% of the company's paid capital is reached. The second set of legal reserves is 10% of the distributed profit exceeding 5% of the paid capital. According to the Turkish Commercial Code, as long as legal reserves do not exceed 50% of the paid-in capital, they can only be used to offset losses and cannot be used in any other way. As a result of the sale of the company's real estate and participation shares, which are evaluated within the scope of Article 5/e of the Corporate Tax Law No. 5520, 75% of the sales profit is classified as "Profit from the sale of real estate and participation shares".

31 March 2025 31 December 2024
Legal reserves 325.291 325.291
Gain on sale of real estate and associate shares 1.606 4.633
R&D investment fund 1.736 1.737
328.633 331.661

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 15 - Capital, reserves and other equity items (Continued)

Retained Earnings

Publicly listed companies distribute dividends in accordance with the requirements of CMB as explained below:

31 March 2025 31 December 2024
Other retained earnigs /(losses) 416.600 371.188
Extraordinary reserves 217.251 239.115
633.851 610.303

As of 31 March 2025 and 2024, the fund items included in shareholders' equity in the financial statements prepared in accordance with the Tax Procedure Law are as follows.

31 March 2025
Retained Earnings CPI Adjusted
Statuary Entrys
PPI Adjusted
Statuary Entrys
Followed
ammount of
Adjustments to share capital 472.380 375.318 97.062
Reserves on retained erning 361.774 328.633 33.141

Dividend distribution

In accordance with the CMB decision numbered 7/242 dated 25 February 2005; If the profit distribution amount calculated in accordance with the CMB's regulations regarding the minimum profit distribution obligation, based on the net distributable profit found in accordance with the CMB regulations, can be fully covered from the distributable profit in the legal records, this entire amount will be distributed, and if not, the entire net distributable profit in the legal records will be distributed. If there is a period loss in the financial statements prepared in accordance with CMB regulations or in any of the legal records, no profit distribution will be made. With the decision of the CMB dated 27 January 2010, it was decided not to impose any minimum profit distribution obligation on dividend distribution for publicly held joint stock companies whose shares are traded on the stock exchange.

Capital increase, free of charge, capital inflation adjustment differences and registered values of extraordinary reserves; It can be used for cash profit distribution or loss offset. However, equity inflation adjustment differences are subject to corporate tax if used in cash profit distribution.

The company management took the profit distribution decision at the general meeting. In case of distribution of these profits, the entire profit distribution amount will be covered from the distributable profit in the legal records.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 16 - Revenue and cost of sales

1 January -
31 March 2025
1 January -
31 March 2024
Domestic sales 393.649 1.291.243
Export sales 26.300 51.427
Sales discounts (-) (142.835) (426.384)
Net sales 277.114 916.286
Cost of sales (-) (170.368) (389.789)
Gross profit 106.746 526.497

The breakdown of the cost of sales by periods is as follows:

1 January -
31 March 2025
1 January -
31 March 2024
Direct material cost 66.696 100.057
Direct labour costs 68.125 70.776
General production expenses 30.369 33.976
Depreciation and amortization expenses 18.184 17.174
Change in semi-finished goods (1.139) (37.024)
Change in finished goods (77.061) 103.435
Cost of products sold 105.174 288.394
Cost of goods sold 65.194 101.395
Cost of sales 170.368 389.789

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 17 - Other operating and investment activities income and expenses

1 January - 1 January -
31 March 2025 31 March 2024
Other income from operating activities
Foreign exchange gain 2.718 6.047
Rediscount interest income - 6.618
Other 186 1.533
2.904 14.198
1 January - 1 January -
31 March 2025 31 March 2024
Other expenses from operating activities
Foreign exchange losses 3.800 5.598
Provision for doubtful trade receivables (Note 7) 495 -
Rediscount interest expense - 54.589
Other 647 674

NOTE 18 - Income and expense from investment activities

1 January - 1 January -
31 March 2025 31 March 2024
Income from investment activities
Gain on sale of property, plant and equipment 1 9 2 7
Other - 5 6
1 9 8 3
1 January - 1 January -
31 March 2025 31 March 2024
Expense from investment activities
Loss on sale of property, plant and equipment - 165
Transfer of foreign currency translation
differences previously recognized in other
comprehensive income to the statement - 6.253
of income
- 6.418

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 19
-
Finance income and expenses
1 January - 1 January -
31 March 2025 31 March 2024
Finance income
Income from derivative transactions 32.924 -
Interest income 10.923 98.177
Foreign exchange income 1.462 14.377
Currency-protected deposit income - 9.851
Interest income from sublease receivables - 280
45.309 122.685
1 January -
31 March 2025
1 January -
31 March 2024
Finance expenses
Interest expenses 132.472 210.126
Foreign exchange losses 1.507 7 2
133.979 210.198

NOTE 20 - Income taxes

The company is subject to taxation within the scope of the tax laws and other legislation of the countries in which it operates.

In Turkey, the corporate tax rate is 25%. The corporate tax return must be declared by the evening of the twenty-fifth day of the fourth month following period. It must be paid in one piece by the end of this month. In accordance with the tax legislation, provisional tax is calculated and paid at the corporate tax rate on the earnings generated quarterly, and the amounts paid in this way are offset from the tax calculated on annual earnings.

In accordance with the tax legislation in Turkey, financial losses can be carried forward for a maximum of five years following the year in which they occurred. In addition, tax declarations and relevant accounting records can be examined by the tax administration within five years.

1 January - 1 January -
31 March 2025 31 March 2024
Current period statutory tax provision (-) - (50.286)
Deferred tax income/(expense) 17.086 9.671
Total deferred tax income, net 17.086 (40.615)
31 March 2025 31 December 2024
Period income tax provision - -
Prepaid tax expenses (-) 123.332 133.949
Profit for the period tax (liability)/receivable, net 123.332 133.949

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 20- Income taxes (Continued)

Tax Advantages Obtained Within the Scope of Investment Incentive System:

The profits obtained by the Company from its investments subject to incentive certificates are subject to corporate tax at reduced rates, starting from the accounting period in which the investment is partially or fully operated, until it reaches the contribution amount to the investment.

Within the scope of the Company's incentive certificates, there is no reduced corporate tax advantage used against the current period legal tax. (31 March 2024: TRL 0)

The company capitalizes its R&D expenditures within the scope of Law No. 5746 in its legal books. According to the provisions of the same law, by calculating the R&D expenditures made by the Company within the framework of the relevant legislation, it benefits from the R&D discount for the part of the R&D expenditures allowed by law.

As of March 31, 2025, the Company has not used the R&D discount advantage in return for legal tax (December 31, 2024: TRL 1.651). The tax advantage of TRL 8.638 (December 31, 2024: not available) that will be used in the future on the unused R&D discount is included in the financial statements as a deferred tax asset. There is a deferred tax expense of TRL 8.638 deducted in the profit or loss statement for the period January 1 - March 31, 2025 related to the deferred tax asset.

Deferred tax assets are recorded when it is determined that taxable income will be generated in the future years. In cases where taxable income is likely to be generated, deferred tax assets are calculated based on deductible temporary differences, tax losses and tax advantages earned due to unlimited-life investment discounts that allow for reduced corporate tax payments. In this context, the Company bases the reflection of deferred tax assets arising from investment incentives on long-term plans and evaluates the recoverability of deferred tax assets related to such investment discounts as of each balance sheet date, based on business models that include taxable profit estimates. It is anticipated that such deferred tax assets will be recovered within 5 years from the balance sheet date.

In the sensitivity analysis conducted as of March 31, 2025, there was no change in the recovery period of deferred tax assets related to investment incentives, which was foreseen as 5 years, when the inputs included in the basic macroeconomic and sectoral assumptions constituting the business plans were increased/decreased by 10%.

Total temprorary differences Deferred tax
31 March 2025 31 December 2024 31 March 2025 31 December 2024
Tangible and intangible assets (8.800) 11.414 (2.200) 2.853
Provision for employment termination benefits 34.700 34.187 8.675 8.547
Turnover and dealer premium provisions 57.444 - 14.361 -
R&D discount 34.552 - 8.638 -
Inventory, provision for impairment on inventories (173.459) (151.618) (43.365) (37.904)
Incentive premium accrual 20.407 12.591 5.102 3.148
Lease services (30.378) (21.446) (7.595) (5.362)
Other adjustments 30.787 9.385 7.694 2.347
Deferred tax asset/(liability), net (34.747) (105.487) (8.690) (26.371)

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 20- Income taxes (Continued)

Tax Advantages Obtained Within the Scope of Investment Incentive System(Continued)

2025 2024
1 January (26.371) 38.298
Deferred tax expense/(income) 17.086 9.671
Severance pay accounted under equity 1.068 (3.821)
effect of remeasurement differences
Impact of derivative financial instruments (473) (686)
31 March (8.690) 43.462

NOTE 21 - Earnings per share

Earnings per share is calculated by dividing the profit for the period by the weighted average number of shares of the Company during the period. The Company's earnings per share calculation is as follows.

1 January - 1 January -
31 March 2025 31 March 2024
Profit /(loss) for the period (200.727) 120.804
Average number of shares
(weighted average number of shares
with a nominal value of TRL 1 per share) 259.875.000 23.625.000
Earnings per share / (loss) (Full TRL) (0,7724) 5,1134

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 22 - Related parties transactions

a) Related Parties' Balances

Receivables from related parties
31 March 2025 31 December 2024
Migros Ticaret A.Ş. (2) 29.432 33.020
A.W.Faber-Castell Vertrieb GmbH (2) 7.382 3.485
A.W.Faber Castell (M) (2) 27.940 -
AEP Anadolu Etap Penkon (2) 1.620 716
A.W.Faber Castell (1) 2.167 -
Anadolu Sağlık Merkezi Hastanesi A.Ş. (2) - 7.429
Other 12.559 2.394
81.100 47.044
Payable to related parties
31 March 2025 31 December 2024
AEH Sigorta Acentalığı A.Ş. (2) 11.891 1 9
AG Anadolu Grubu Holding A.Ş. (1) 8.271 7.362
A.W.Faber Castell Brezilya S.A. (2) 231 237
Other 8 4 294
20.477 7.912

1) Partners

2) Related party of AG Anadolu Grubu Holding A.Ş. and Faber-Castell Aktiengesellschaft (a shareholder)

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 22 - Related parties transactions (Continued)

b) Related Parties' transactions

1 January - 1 January -
31 March 2025 31 March 2024
Purchases of goods
A.W.Faber-Castell Vertrieb GmbH (2) 1.325 4.072
A.W.Faber Castell (M) Sdn.Bhd. (2) 11.265 -
P.T.A.W.Faber Castell Ind. (2) 2.423 6.765
15.013 10.837
1 January - 1 January -
31 March 2025 31 March 2024
Sales of goods
Migros Ticaret A.Ş. (2) 23.850 83
A.W.Faber-Castell Vertrieb GmbH (2) - 2.036
A.W.Faber Castell Brazil S.A.(2) - 910
Other 354 78
24.204 3.107
1 January - 1 January -
31 March 2025 31 March 2024
Services received
AG Anadolu Grubu Holding A.Ş. (1) 18.267 16.251
Anadolu Efes Spor Kulübü (2) 10.242 -
Diğer 98 16
28.607 16.283
1 January - 1 January -
31 March 2025 31 March 2024
Services given
Anadolu Kafkasya Enerjı Yatırımları A.Ş. (2) 1.050 1.062
AEP Anadolu Etap Penkon Gıda ve Tarım Ürün San ve Tic A.Ş (2) 4.868 4.249
Other 61 356
5.979 6.023

1) Partners

2) Related party of AG Anadolu Grubu Holding A.Ş. and Faber-Castell Aktiengesellschaft (a shareholder)

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 22 - Related parties transactions (Continued)

c) Benefits provided to key management

Key management personnel consist of the Head of the Agriculture, Energy and Industry Group, the General Manager and the managers who report directly to the General Manager. Benefits for senior executives are as follows:

2025 2024
Short-term employee benefits 39.112 29.169
Other long-term benefits 3.519 861
31 March 47.993 30.030

NOTE 23 - Nature and level of risks arising from financial instruments

(a) Capital risk management

The Company manages its capital to ensure that it will maintain its status as a going concern while maximizing the return to stakeholders through the optimization of the debt and equity balance, The capital structure of the Company consists of debt, which includes the borrowings and other debts, cash and cash equivalents and equity attributable to equity holders of the parent, comprising issued capital, reserves and retained earnings.

The management of the Company considers the cost of capital and the risks associated with each class of capital. The management of the Company aims to balance its overall capital structure through the payment of dividends, new share issues and the issue of new debt or the redemption of existing debt. The Company controls its capital using the net debt / total equity ratio. This ratio is the calculated as net debt divided by total equity.

Net debt is calculated as total liability (comprises of financial liabilities, leasing and trade payables as presented in the statement of financial position) less cash and cash equivalents.

As of 31 March 2025 and 31 December 2024, net debt/(equity+net debt) ratio is as follows:

31 March 2025 31 December 2024
Total borrowings 1.156.579 1.109.021
Less: Cash and cash equivalents (475.773) (725.684)
Net debt 680.806 383.337
Total equity 1.392.234 1.594.908
Total equity + net debt 2.073.040 1.978.245
Net debt / (total equity+net debt) ratio 33% 19%

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 23 - Nature and level of risks arising from financial instruments (Continued)

(b) Credit risk

Financial instruments have a counterparty risk as they may not fulfill requirements of the agreement. The Company manages credit risk by constantly evaluating the credibility of the related parties and by determining counterparty credit limits and due dates on a customer basis. Company also receives collaterals from customers as needed. Instruments that increase the credit reliability as guarantees received to determine the maximum amount of credit risk as of reporting date, are not taken into account.

Concentrations of credit risk arise when a number of counterparties are engaged in similar business activities or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations to be similarly affected by changes in economic, political or other conditions. Concentrations of credit risk indicate the relative sensitivity of the Company's performance to developments affecting a particular industry or geographic location.

(c) Currency risk and management

Transactions in foreign currency cause the exchange rate risk to occur.

The Company is exposed to exchange rate risk due to changes in the exchange rates used in the conversion of foreign currency assets and liabilities into Turkish lira. Currency risk arises due to future commercial transactions and the difference between recorded assets and liabilities.

The TRL equivalents of foreign currency assets and liabilities held by the Company are as follows:

31 March 2025 31 December 2024
Assets 103.407 72.661
Liabilities (62.043) (19.772)
Net balance sheet foreign currency position 41.364 52.889

The Company is exposed to currency risk mainly in US Dollar and Euro.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 23 - Nature and level of risks arising from financial instruments (Continued)

Profit/Loss 31 March 2025 Appreciation of
foreign currency
Depreciation
foreign currency
If the US Dollar changes 20% +/- against TRL :
1- USD net asset/liability 7.478 (7.478)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 7.478 (7.478)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability 795 (795)
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) 795 (795)
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
8.273 (8.273)
Profit/Loss 31 December 2024 Appreciation of
foreign currency
Depreciation
foreign currency
If the US Dollar changes 20% +/- against TRL :
1- USD net asset/liability 10.095 (10.095)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 10.095 (10.095)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability
483 (483)
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) 483 (483)
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
10.578 (10.578)

(*) The effect of derivative instruments for hedging purposes is not taken into account.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 23 - Nature and level of risks arising from financial instruments (Continued)

It summarizes the Company's foreign currency position risk. The recorded amounts of foreign currency assets and liabilities held by the Company are as follows. by foreign currency type:

31 March 2025 31 December 2024
TRL equivalent USD Avro Other TRL equivalent USD Avro Other
1. Trade receivables 16.638 352 82 - 16.562 285 136 -
2a. Monetary financial assets 11.675 278 29 - 38.767 1.000 - -
2b. Non-monetary financial assets - - - - - - - -
3. Other 75.094 1.791 183 - 17.331 432 15 -
4. Total current assets (1+2+3) 103.407 2.421 294 - 72.660 1.717 151 -
5. Trade receivables - - - - - - - -
6a. Monetary financial assets - - - - - - - -
6b. Non-monetary financial assets - - - - - - - -
7. Other - - - - - - - -
8. Total non-current assets (5+6+7) - - - - - - - -
9. Total assets (4+8) 103.407 2.421 294 - 72.660 1.717 151 -
10. Trade payables 57.541 1.314 195 - 15.986 319 90 -
11. Financial liabilities - - - - - - - -
12a. Other monetary liabilities 4.502 118 1 - 3.785 96 1 -
12b. Othre non-monetary liabilities - - - - - - - -
13. Total current liabilities (10+11+12) 62.043 1.432 196 - 19.771 415 9 1 -
14. Trade payables - - - - - - - -
15. Financial liabilities - - - - - - - -
16a. Other monetary liabilities - - - - - - - -
16b. Other non-monetary liabilities - - - - - - - -
17. Total non-current liabilities (14+15+16) - - - - - - - -
18. Total liabilities (13+17) 62.043 1.432 196 - 19.771 415 9 1 -
19. Net asset/ (liability) position of off-balance sheet derivative instruments
(19a-19b)
120.850 3.200 - - 155.071 4.000 - -
19a. Total asset amount hedged 120.850 3.200 - - 155.071 4.000 - -
19b. Total liabilities amount hedged - - - - - - - -
20. Net foreign currency asset / (liability) position (9-18+19) 162.214 4.189 9 8 - 207.960 5.302 6 0 -
21. Monetary items net foreign currency asset / (liability) position
(1+2a+3+5+6a-10-11-12a-14-15-16a)
41.364 989 9 8 - 52.889 1.302 6 0 -
22. Total fair value of financial instruments used for currency hedge - - - - - - - -
23. Exports 26.300 606 5 9 1.258 138.667 2.191 696 6.680
24. Imports 92.312 2.333 165 - 504.731 10.419 3.349 9 5
% 20 increase - 7.478 795 - - 9.172 439 -

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 23 - Nature and level of risks arising from financial instruments (Continued)

(d) Interest rate risk and management

As of 31 March 2025, the Company does not have any floating rate borrowings. (31 December 2024: None).

(e) Credit risk management

Holding financial instruments also carries the risk that the other party will not be able to fulfill the requirements of the agreement. The Company's collection risk mainly arises from its trade receivables. Trade receivables are evaluated taking into account the Company policies and procedures and accordingly, they are shown in the balance sheet net after provision for doubtful receivables.

The majority of the Company's sales are for the domestic market and it is mainly carried out through dealers and wholesalers. About 55% of the sales are due to the sales of the manufactured products. The commercial goods sold by the Company are of foreign origin. Therefore the company's merchandise costs are sensitive to the exchange rate. The cost of raw materials depends on the general price trend in the country. Approximately 91% of the Company's net sales are domestically oriented and the fluctuations in exchange rates are taken into account when determining price levels.

The Company collects its receivables mainly through checks received from its dealers and also uses a direct debit system (DBS). Since the issuers of the checks received in general are the customers of the dealers, risk distribution is provided. Due to the fact that the Company operates in this system, there is no significant risk arising from its receivables.

(f) Liquidity risk and management

The Company tries to manage its liquidity risk by regularly monitoring the cash flows and ensuring the continuation of sufficient funds and borrowing reserves by matching the maturities of financial assets and liabilities.

Liquidity risk tables

Prudent liquidity risk management refers to holding sufficient cash, availability of sufficient credit transactions and fund resources, and the power to close market positions.

The funding risk of current and prospective debt requirements is managed by maintaining the availability of sufficient number of high-quality lenders.

The maturity distribution of the Company's derivative and non-derivative financial liabilities in TRL terms is shown below.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 24 - Financial instruments

24.1 Fair value

The Company considers that the recorded values of financial instruments reflect their fair values.

Fair value hedge accounting

Level 1: Market price valuation techniques for the determined financial instruments traded in markets (unadjusted)

Level 2: Other valuation techniques including direct or indirect observable inputs Level 3: Valuation techniques not containing observable market inputs

31 March 2025 Level 1 Level 2 Level 3
Derivative financial assets 1.766 - 1.766 -
31 December 2024 Level 1 Level 2 Level 3
Derivative financial assets - - - -
31 March 2025 Level 1 Level 2 Level 3
Derivative financial liabilities - - - -
31 December 2024 Level 1 Level 2 Level 3
Derivative financial liabilities 617 - 617 -

24.2 Derivative financial instruments and hedge accounting

Derivative financial instruments are initially recognized at cost, and subsequently valued at fair value on 1 October 2018.

As of 31 March 2025, Adel has a foreign exchange forward transaction with a nominal value of TRL 120.850 amounting to USD 3.200.000 (31 December 2024: Nominal value of TRL 195.579 amounting to USD 4.000.000).

As of 31 March 2025, the Company has allocated USD 309.137 equivalent of TRL 11.675 from its bank deposits for the payments related to raw material and trade goods purchases to be made in the future periods in order to hedge against fluctuations in foreign exchange rates and the related amount has been subject to hedge accounting. (31 December 2024: USD 1.000.000 equivalent of TRL 48.644)

The Company documented the relationship between hedging instruments and hedged items at the beginning of the hedge transaction and also documented risk management objectives and the strategy for performing a variety of hedging transactions. Company, both at the beginning of the process of hedging transaction and on a regular basis of the hedging transaction, documented the assessment whether instruments used in hedging transactions are effective in high-level balancing changes in values of hedged items.

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 24 - Financial instruments (Continued)

24.2 Derivative financial instruments and hedging transactions (Continued)

2025 2024
Fair Values Fair Values
Contract Amount Asset Liability Contract Amount Asset Liability
For hedging purposes:
Forward transaction 120.850 1.766 - 155.071 - 617
120.850 1.766 - 155.071 - 617
Short term 120.850 1.766 - 155.071 - 617
120.850 1.766 - 155.071 - 617

Objectives in financial risk management:

The Company's finance department is responsible for ensuring regular access to financial markets and monitoring and managing the financial risks incurred in connection with the Company's activities. These risks are; It includes market risk (including currency risk, fair interest rate risk and price risk), credit risk, liquidity risk and cash flow interest rate risk. The Company does not have speculative financial instruments (including derivative financial instruments) and does not have any activity related to the purchase and sale of such instruments.

31 March 2025 Notes Fair value
differences
reflected in
other
Financial
assets shown at
amortized cost
Financial
liabilities
shown at
amortized
Book value Fair value
Financial assets
Cash and cash equivalences 4 - 475.773 - 475.773 475.773
Trade receivables from third parties 7 - 96.173 - 96.173 96.173
Receivables from related parties 2
2
- 81.100 - 81.100 81.100
Other financial assets 5 - 1.409 - 1.409 1.409
Financial liabilities
Financial borrowings 6 - - 987.968 987.968 987.968
Lease liabilities 6 - - 168.611 168.611 168.611
Trade payables 7 - - 154.180 154.180 154.180
Payables from related parties 2
2
- - 20.477 20.477 20.477
Other financial liabilities 8
-
-
-
-
-
3.973
-
3.973
-
3.973
-
31 December 2024 Notes Fair value
differences
reflected in
other
Financial
assets shown at
amortized cost
Financial
liabilities
shown at
amortized
Book value Fair value
Financial assets
Cash and cash equivalences 4 - 725.684 - 725.684 725.684
Trade receivables from third parties 7 - 97.365 - 97.365 97.365
Receivables from related parties 2
2
- 47.044 - 47.044 47.044
Other financial assets 5 - 1.436 - 1.436 1.436
Financial liabilities
Financial borrowings 6 - - 961.932 961.933 961.933
Lease liabilities 6 - - 147.089 147.089 147.089
Trade receivables from third parties 7 - - 138.431 138.431 138.431
Payables from related parties 2
2
- - 7.912 7.912 7.912
Derivatives 24.2 - - 617 617 617
Other financial liabilities 8 - - 4.214 4.214 4.214

ADEL KALEMCİLİK TİCARET VE SANAYİ ANONİM ŞİRKETİ NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 31 MARCH 2025

(Currency expressed in Turkish Lira based on the purchasing power of Turkish Lira ("TRL") as of March 31,2025, unless otherwise stated)

NOTE 25 - Disclosures on net monetary position gains / (losses)

31 March 2025 31 March 2024
Financial Position Statement Items
Inventory 84.001 137.780
Prepaid expenses 2.380 3.001
Financial investments 9 13
Property, plant and equipment 79.117 115.587
Intangible assets 8.838 15.843
Right of use assets 19.272 27.475
Deferred income (2.402) (19.560)
Adjustment to share capital (58.074) (83.157)
Other comprehensive expenses that will not be reclassified to profit or loss (6.869) (7.178)
- Losses on remeasurement of defined benefit obligations (6.869) (7.178)
Other comprehensive income (expenses) that will be reclassified to profit or loss (1.254) (1.214)
- Currency translation differences 1 819
- Gains (loss) on hedge (1.255) (2.033)
Restricted reserves (27.753) (41.076)
Retained earnings (60.244) (108.526)
Profit or Loss Statement Items
Revenue (1.319) (11.077)
Cost of sales (-) 784 5.443
Research and development expenses (-) 207 128
General administrative expenses (-) 3.112 4.067
Marketing expenses (-) 3.392 5.030
Other income from operating activities (62) (238)
Other expenses from operating activities (-) 94 179
Income from investment activities (1.056) -
Finance income (83) (4.405)
Finance expenses (-) 3.061 6.125
Taxes on expense - 1.643
Deferred tax income (2.411) 5.014
Other Comprehensive Income Statement Items
Other comprehensive income (expenses) that will not be reclassified 8.370 10.044
NET MONETARY POSITION GAINS / (LOSSES) 51.110 60.941

NOTE 26 - Events after the reporting period

The Board of Directors' decision regarding the distribution of TRL 150.026 gross dividend to fully taxpayer institutions at a rate of 57,73% gross in the amount of full TRL 0,5773 for each share with a nominal value of full TRL 1 and TRL 0,490705 net in the amount of full TRL 49,07% for each share with a nominal value of full TRL 1 to other shareholders, taking into account our company's unconsolidated financial statements prepared in accordance with the capital markets legislation, VUK legal records and tax legislation, all of which will be covered from the previous year's profits (extraordinary reserves), and also the allocation of TRL 13.703 as a second series legal reserve for these dividends to be distributed, and the dividend payment date being September 26, 2025, was approved at the Ordinary General Assembly Meeting dated April 16, 2025.

Talk to a Data Expert

Have a question? We'll get back to you promptly.